The Social Costs of Delaying Effective Cancer Treatment Using CAR-T Immunotherapy
CAR-T therapy can save lives and boost benefits to society … if it’s delivered promptly, says Cartherics CEO and Executive Director, Alan Trounson
5 September 2019
Using the tools of biotechnology and immunology to help transforming cancer from a fatal to a manageable — or even curable – disease holds profound benefits to individual patients and the […]